Juying Wei

机构：Precision for Medicine (United States), Zhejiang Hospital, Zhejiang Lab, Zhejiang Provincial People's Hospital, Zhejiang Center for Disease Control and Prevention, Second Affiliated Hospital of Zhejiang University, Hangzhou Cancer Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University

发表论文 113 篇 · 总被引 872 次 · h-index 16

代表论文

• Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China (2025 · Blood · 被引 23)
• IFN-γ promotes the progression of iMCD by activating inflammatory monocytes (2025 · Blood · 被引 6)
• Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study (2025 · Haematologica · 被引 3)
• Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial (2025 · Blood Cancer Journal · 被引 2)
• Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia (2025 · MedComm · 被引 1)
• Orelabrutinib combined with bendamustine-rituximab or obinutuzumab followed by orelabrutinib maintenance in untreated marginal zone lymphoma (Optimize): A multicenter, single-arm, phase II study (2025 · Blood · 被引 1)